A new technology to analyze brain injuries using tiny particles from the brain.
A nanomagnetic platform technology to characterize traumatic brain injury using brain derived extracellular vesicles
This study is looking at a new way to understand traumatic brain injuries by using tiny chips to analyze brain signals, which could help doctors better recognize how serious the injury is, especially in mild cases, and improve care for patients recovering from these injuries.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10465255 on NIH RePORTER |
What this research studies
This research focuses on developing a microchip-based platform to better understand traumatic brain injuries (TBI) by analyzing RNA found in brain-derived extracellular vesicles. It aims to identify unique molecular markers that can help classify the severity of TBIs, especially in mild cases where traditional imaging methods fall short. By using machine learning algorithms, the study seeks to create a comprehensive profile of the injury and recovery process, which could lead to improved patient outcomes. This innovative approach could provide insights into the long-term effects of TBIs, such as seizures and emotional issues.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have experienced a traumatic brain injury, particularly those with mild cases.
Not a fit: Patients with severe traumatic brain injuries or those who do not have access to the research facility may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate diagnoses and personalized treatment plans for individuals suffering from traumatic brain injuries.
How similar studies have performed: Other research has shown promise in using molecular markers for brain injuries, but this specific approach utilizing extracellular vesicles is relatively novel.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Issadore, David Aaron — University of Pennsylvania
- Study coordinator: Issadore, David Aaron
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.